Patents by Inventor Noel A. Roberts

Noel A. Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6984729
    Abstract: The present invention discloses synthetic oligonucleotides complementary to contiguous and noncontiguous regions of the HBV RNA. Also disclosed are methods and kits for inhibiting the replication and expression of HBV, and for treating HBV infections and associated conditions.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: January 10, 2006
    Assignee: Hybridon, Inc.
    Inventors: Bruce L. Frank, Peter C. Roberts, John Goodchild, J. Charles Craig, John S. Mills, Andrew Slade, Robert E. Kilkuskie, Noel A. Roberts, Raymond Jupp
  • Patent number: 4623639
    Abstract: The present invention provides for peptide derivatives, a process for their manufacture and pharmaceutical preparations containing the same. The invention is also concerned with novel intermediates used in the manufacture of said derivatives.
    Type: Grant
    Filed: July 5, 1984
    Date of Patent: November 18, 1986
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Cedric H. Hassall, William H. Johnson, Noel A. Roberts
  • Patent number: 4612324
    Abstract: Compounds of the formula ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 each individually is hydrogen, or lower alkyl and R.sup.4 is hydroxy, lower alkoxy, aryl-(lower alkoxy), amino, mono(lower alkyl)amino or di(lower alkyl) amino,and pharmaceutically acceptable salts thereof which are useful in the treatment of degenerative joint diseases and of Wilson's disease are described.
    Type: Grant
    Filed: February 1, 1984
    Date of Patent: September 16, 1986
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Colin H. Cashin, Noel A. Roberts, Brian P. Tong
  • Patent number: 4187216
    Abstract: The present disclosure relates to dipeptide derivatives. These novel compounds are useful as elastase inhibitors.
    Type: Grant
    Filed: June 8, 1977
    Date of Patent: February 5, 1980
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Cedric H. Hassall, William H. Johnson, Noel A. Roberts
  • Patent number: 4176116
    Abstract: The present disclosure relates to dipeptide derivatives. The novel compounds are useful as elastase inhibitors.
    Type: Grant
    Filed: June 8, 1977
    Date of Patent: November 27, 1979
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Cedric H. Hassall, William H. Johnson, Noel A. Roberts